During the global spread of the novel coronavirus, the ensuing COVID-19 pandemic and, now, efforts to engage in reopening, much has been said about strategies aimed at helping control infection in our daily lives.
However, what about in the very facilities treating not only patients with COVID-19, but those with other conditions?
Hospital-acquired infections, those acquired in the hospital or place of treatment as opposed to prior to arriving at those facilities, can throw a major wrench in practices’ and hospitals’ ability to effectively care for patients.
Vioguard Vice President of Sales and Marketing, Mark Beeston, joined host Daniel Litwin to outline the company’s mission – improving infection control and helping curtail hospital-acquired infections – and how it goes about achieving those goals.
“[COVID-19] heightened awareness in the healthcare space,” Beeston said. “There were processes in place, already, but those processes have now been enhanced. You’re seeing more diligence in areas that are really hypersensitive.”
This heightened diligence has particularly affected places like newborn ICUs and operating rooms, and even families of patients are being more thoroughly screened and sanitized. It’s also increased attention on aspects of exposure that might have previously been overlooked, such as visitor cellphones.
Established in 2008, Vioguard develops solutions that utilize ultraviolet light to aid in sanitization efforts, working to provide effective infection control measures that don’t interfere with productivity or accuracy.
Litwin and Beeston explored how and why healthcare professionals might spread infection, the current state of prevention, and immediate and long-term strategies for avoiding hospital-acquired infections.
Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale
